The board of directors of Libra Infusions Limited has recommended 30 per cent cash dividend for the year ended on June 30, 2017, said an official disclosure on Thursday.
The final approval of dividend will come during the annual general meeting (AGM) scheduled to be held on December 20 at 11:00am at the Factory Premises in Dhaka.
The record date for entitlement of dividend is on November 16, 2017.
The company has also reported earnings per share (EPS) of Tk 4.86, net asset value (NAV) per share of Tk 1,578 and net operating cash flow per share (NOCFPS) of Tk 1.75 for the year ended on June 30, 2017 as against Tk 4.65, Tk 1,576 and Tk. 56.49 respectively for the same period of the previous year.
In 2016, the company disbursed 25 per cent cash dividend.
There will be no price limit on the trading of the shares of the Company on today (Thursday) following its corporate declaration.
Each share of Libra Infusions, which was listed on the Dhaka bourse in 1994, closed at 565.30 on Wednesday at the Dhaka Stock Exchange (DSE).
The company’s paid-up capital is Tk 12.52 million and authorised capital is Tk 100 million, while the total number of securities is 1.25 million.
Sponsor-directors own 34.43 per cent stake in the company, while institutional investors own 13.86 per cent and the general public 51.71 per cent as on September 30, 2017, the DSE data shows.